Tenax Therapeutics
TENX
Tenax Therapeutics (TENX) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.27
- EPS estimate
- −$0.27
- EPS surprise
- −1.43%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 13, 2025 | −$0.27 | −$0.27 | −1.43% | $0.00 | SEC |
| Q1 2025 | May 14, 2025 | −$0.19 | −$0.28 | −44.85% | $0.00 | SEC |
| Q4 2024 | Mar 25, 2025 | −$0.16 | −$0.18 | −14.87% | $0.00 | SEC |
| Q3 2024 | Nov 13, 2024 | −$1.37 | −$0.19 | +86.12% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$1.99 | −$1.83 | +7.81% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$2.40 | −$3.12 | −30.00% | $0.00 | SEC |
| Q4 2023 | Mar 28, 2024 | −$9.99 | −$10.90 | −9.06% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$7.20 | −$6.61 | +8.19% | $0.00 | SEC |
| Q4 2022 | Mar 31, 2023 | −$212.40 | −$127.20 | +40.11% | $0.00 | SEC |
| Q1 2021 | May 17, 2021 | −$336.00 | −$2,624.00 | −680.95% | $0.00 | — |
| Q4 2020 | Mar 31, 2021 | −$224.00 | −$272.00 | −21.43% | $0.00 | — |
| Q3 2020 | Nov 16, 2020 | −$232.00 | −$288.00 | −24.14% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Tenax Therapeutics (TENX) last report earnings?
Tenax Therapeutics last reported on Aug 13, 2025, covering fiscal Q2 2025.
Did TENX beat earnings estimates?
No. Tenax Therapeutics reported EPS of −$0.27 for Q2 2025 against a −$0.27 estimate — a 1.43% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.